Advertisement

Topics

Elan Corporation, plc and Transition Therapeutics, Inc. Company Profile

16:28 EST 21st November 2017 | BioPortfolio


News Articles [803 Associated News Articles listed on BioPortfolio]

Coming In Tuesday's "The Pink Sheet" DAILY - Royalty Pharma Makes A Move For Elan

Royalty Pharma’s $11 per-share bid for Elan is too low, according to Elan’s management and industry analysts.

Transition Therapeutics licenses drug candidate from Eli Lilly

Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") fro...

Latest News From "The Pink Sheet" DAILY - Royalty Pharma Makes A Play For Elan

For Elan Investors, A Choice Between A Sure Thing Or A High-Risk Play

New Management by Civitas Brings Exciting Changes to Elan Santa Monica

ALBUQUERQUE, N.M., Sept. 6, 2017 /PRNewswire/ -- Civitas Senior Living, a privately owned senior living and consulting company, announced on September 1 that it has been awarded the management contrac...

Civitas Named Managing Company for Elan Southpark Meadows

AUSTIN, Texas, Sept. 7, 2017 /PRNewswire/ -- Civitas Senior Living, a Texas-based senior living and consulting company, announced on September 1 that it has been awarded the management contract for El...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Sarepta Therapeutics Names Basi Chief Scientific Officer

Sarepta Therapeutics (NASDAQ: SRPT) has a new chief scientific officer. Guriqbal Basi has been appointed to the post, where he will oversee the Cambridge, MA, company’s rare disease drug pipeline. B...

PubMed Articles [1258 Associated PubMed Articles listed on BioPortfolio]

Understanding B-DNA to A-DNA transition in the right-handed DNA helix: Perspective from a local to global transition.

The right-handed DNA helix exhibits two major conformations, A-DNA and B-DNA, depending on the environmental conditions. The B-DNA to A-DNA (B→A) transition is sequence specific, cooperative, and re...

Assessing the Transition Intervention Needs of Young Adults With Inflammatory Bowel Diseases.

The transition of inflammatory bowel disease (IBD) patients from pediatric to adult care can be challenging. Developing an effective transition intervention requires assessing the current transition e...

Calculating transition rates from durations of transition paths.

Calculating the kinetic rates for rare transitions is an important objective for molecular simulations. Here I prove equalities that relate the transition rates to the equilibrium free energy and the ...

Health and wellbeing during transition to adulthood for young people with intellectual disabilities: A qualitative study.

Transition to adulthood may have negative consequences for health and wellbeing in individuals with intellectual disabilities (ID), but this aspect of transition has received little investigation. Thi...

Using Quality Improvement in Resident Education to Improve Transition Care.

The importance of a specific transition process is recognized by many health organizations. Got Transition, a cooperative endeavor aimed at improving the transition from pediatric to adult health care...

Clinical Trials [423 Associated Clinical Trials listed on BioPortfolio]

Open-Label Extension Study

The purpose of this study is to evaluate the long-term safety, tolerability and activity of Fampridine-SR in subjects with multiple sclerosis who have previously participated in either an ...

Evaluation of Web-based Transition Education to Enhance Transition Readiness

The study looks to learn more about the helpfulness of web-based transition education and its effect on transition readiness and health service utilization in the adolescent and young adul...

Tailored Transition for IBD Adolescents

Background: Smooth transition of adolescent patients diagnosed with inflammatory bowel diseases (IBD) to adult care is necessary in order to secure continues clinical management and to pre...

Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial

The Transition Navigator Trial (TNT) is a pragmatic randomized controlled trial evaluating the effectiveness of usual care plus a patient navigator service versus usual care plus newslette...

Improving Health Care Transition for Youth With Special Needs

Special opportunities exist in vulnerable populations with chronic conditions to better understand what life course factors can facilitate attainment of optimal health and development. One...

Companies [1456 Associated Companies listed on BioPortfolio]

Elan Corporation, plc and Transition Therapeutics, Inc.

Elan Corporation, plc

Elan Corporation, plc is a neuroscience-based biotechnology company focused on discovering and developing advanced therapies in neurodegeneration and autoimmune diseases, and real...

Elan plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing i...

Elan Corporation plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by bringing innovations in science...

Elan, plc

Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing i...

More Information about "Elan Corporation, plc and Transition Therapeutics, Inc." on BioPortfolio

We have published hundreds of Elan Corporation, plc and Transition Therapeutics, Inc. news stories on BioPortfolio along with dozens of Elan Corporation, plc and Transition Therapeutics, Inc. Clinical Trials and PubMed Articles about Elan Corporation, plc and Transition Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elan Corporation, plc and Transition Therapeutics, Inc. Companies in our database. You can also find out about relevant Elan Corporation, plc and Transition Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record